| Date Filed | Type | Description |
| 04/13/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/09/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/06/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Ra Pharmaceuticals, Inc. |
| 04/03/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 04/02/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/02/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 04/02/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/02/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 04/02/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/31/2020 |
8-K
| Quarterly results |
| 03/13/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 02/28/2020 |
8-K
| Quarterly results |
| 02/27/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/18/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events |
| 12/06/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/25/2019 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against Ra Pharmaceuticals, Inc. |
| 11/25/2019 |
8-K
| Other Events |
| 11/23/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – RARX, IPHS, CISN, LPT |
| 11/16/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders – WLH, CISN, RARX, TECD |
| 11/15/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, RARX, and IPHS Shareholders About Its Ongoing Investigations |
| 11/15/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 11/11/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – IPHS, INXN, RARX, VSI |
| 11/08/2019 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0.4% stake in Ra Pharmaceuticals, Inc. |
| 11/07/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 11/04/2019 |
GN
| Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – VSI, RARX, SRCI, UCFC |
| 11/04/2019 |
GN
| MERGER ALERT – RARX, EMPK, and CETV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 11/01/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, and RARX Shareholders About Its Ongoing Investigations |
| 11/01/2019 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 10/29/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations |
| 10/24/2019 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
|